Gengchen Xie
- Topics
- DNA Repair Mechanisms (3 papers)Cancer Immunotherapy and Biomarkers (3 papers)MicroRNA in disease regulation (3 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Gengchen Xie
19 papers receiving 406 citations
Peers
Comparison fields: 5 of 67
- Molecular Biology 194
- Oncology 143
- Immunology 119
- Cancer Research 75
- Surgery 61
Countries citing papers authored by Gengchen Xie
This map shows the geographic impact of Gengchen Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gengchen Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gengchen Xie more than expected).
Fields of papers citing papers by Gengchen Xie
This network shows the impact of papers produced by Gengchen Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gengchen Xie. The network helps show where Gengchen Xie may publish in the future.
Co-authorship network of co-authors of Gengchen Xie
This figure shows the co-authorship network connecting the top 25 collaborators of Gengchen Xie. A scholar is included among the top collaborators of Gengchen Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gengchen Xie. Gengchen Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 13 | |
| 5 | 2 | |
| 6 | 4 | |
| 7 | 6 | |
| 8 | 3 | |
| 9 | 9 | |
| 10 | 10 | |
| 11 | 50 | |
| 12 | 7 | |
| 13 | 27 | |
| 14 | 55 | |
| 15 | 7 | |
| 16 | Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancer. | 45 |
| 17 | 48 | |
| 18 | 30 | |
| 19 | 65 | |
| 20 | 33 |
About Gengchen Xie
Gengchen Xie is a scholar working on Applied Microbiology and Biotechnology, Cancer Research and Oncology, having authored 20 papers that have together received 420 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Immunology (119 citations), Oncology (143 citations) and Cancer Research (75 citations). Gengchen Xie has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Yuping Yin, Kaixiong Tao, Yaxin Wang, Ende Zhao, Ruidong Li, Liang Shi, Di Wang, Kaixiong Tao, Ruidong Li and Di Wang. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.